e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
233.86
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Mar 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
615
Open
233.86
Bid (Size)
233.31 (100)
Ask (Size)
235.40 (100)
Prev. Close
233.86
Today's Range
233.86 - 233.86
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
2.96%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
March 03, 2026
As of March 3, 2026, Viatris Inc. (NASDAQ: VTRS) stands at a pivotal crossroads in its corporate evolution. Formed less than six years ago through one of the most complex healthcare mergers in recent...
Via
Finterra
Topics
Economy
Initial Public Offering
Retirement
Why AbbVie Stock May Be the Ultimate Option for Dividend Investors
↗
March 02, 2026
AbbVie pays a high dividend, has grown its payout regularly, and has a strong underlying business.
Via
The Motley Fool
Topics
Economy
Performance
YTD
+2.0%
+2.0%
1 Month
+3.6%
+3.6%
3 Month
+4.2%
+4.2%
6 Month
+10.4%
+10.4%
1 Year
+10.6%
+10.6%
More News
Read More
Where Will AbbVie Be in 5 Years?
↗
February 26, 2026
Via
The Motley Fool
Topics
Intellectual Property
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
February 25, 2026
Via
MarketMinute
Topics
Intellectual Property
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises
↗
February 25, 2026
Via
Stocktwits
Topics
Intellectual Property
This High‑Yield Pharma Beast AbbVie Could Turn Dividends Into Life‑Changing Income
↗
February 24, 2026
Via
The Motley Fool
Topics
ETFs
Intellectual Property
Axsome Therapeutics (AXSM): A CNS Powerhouse at a Commercial Crossroad
February 23, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
1 Cash-Producing Stock to Target This Week and 2 We Ignore
February 22, 2026
Via
StockStory
3 Stocks to Buy and Hold for 2026 and Beyond
↗
February 19, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
2 Dividend Stocks to Hold for the Next 5 Years
↗
February 19, 2026
Via
The Motley Fool
Topics
Energy
Intellectual Property
What's going on in today's session: S&P500 movers
↗
February 18, 2026
Via
Chartmill
6 Forever Dividend Stocks
↗
February 18, 2026
Via
The Motley Fool
1 Mega-Cap Stock on Our Watchlist and 2 We Avoid
February 17, 2026
Via
StockStory
8 Cheap Stocks to Buy in 2026
↗
February 16, 2026
Via
The Motley Fool
1 No-Brainer Dividend Stock to Buy on the Dip
↗
February 15, 2026
Via
The Motley Fool
Topics
Intellectual Property
5 Best Stocks to Buy in February
↗
February 15, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
3 Dividend Stocks to Hold for the Next 20 Years
↗
February 15, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
↗
February 14, 2026
Via
The Motley Fool
Topics
Stocks
Got $500? 2 Pharma Stocks to Buy and Hold Forever.
↗
February 14, 2026
Via
The Motley Fool
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Government
The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
1 Reason I'm Never Selling AbbVie Stock
↗
February 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
February 11, 2026
Via
Finterra
Topics
Economy
Intellectual Property
The 5 Most Interesting Analyst Questions From AbbVie’s Q4 Earnings Call
February 11, 2026
Via
StockStory
Topics
Earnings
Silver and Gold Prices Are Volatile. Buy This ETF for Safety This Year
↗
February 10, 2026
Via
The Motley Fool
Topics
ETFs
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 233.86
When was AbbVie last traded?
The last trade of AbbVie was at 03/03/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert